SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-21-001314
Filing Date
2021-05-13
Accepted
2021-05-13 16:16:18
Documents
1
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3744
  Complete submission text file 0001593968-21-001314.txt   5202
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, 37TH FL NEW YORK NY 10001
Business Address
Miller-Rich Nancy (Reporting) CIK: 0001735084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 21919853